HeartRhythm

JANUARY 13, 2024

The increased risk of arrhythmias and sudden cardiac death (SCD) caused by drug-induced QT prolongation has been a prominent safety pharmacology concern for the last 30 years.

Sudden Cardiac Death 71

Sudden Cardiac Death Pharmacology Arrhythmia 71

HeartRhythm

APRIL 30, 2024

Supraventricular tachycardias are the most common arrhythmias that occur during pregnancy. Pharmacologic therapy is often preferred in pregnant patients. When pharmacologic therapy fails, fluoroless catheter ablation utilizing electroanatomic mapping systems and intracardiac echocardiography (ICE) may be considered.

Tachycardia 40

Tachycardia Ablation Pharmacology Arrhythmia 40

Journal of Cardiovascular Pharmacology

NOVEMBER 11, 2024

Intravenous (IV) digoxin loading dose recommendations for rate control of atrial arrhythmias in critically ill patients are not well studied. Intravenous (IV) digoxin loading dose recommendations for rate control of atrial arrhythmias in critically ill patients are not well studied. ng/mL is recommended. ng/mL is recommended.

Arrhythmia 40

Arrhythmia Atrial Flutter Atrial Fibrillation Outcomes 40

Open Heart

JULY 28, 2023

Introduction The incidence of arrhythmia in heart failure with non-reduced ejection fraction (HFnon-rEF) in patients who have a history of hospitalisation is unclear. Methods and analysis This is a multicentre single arm study to evaluate the usefulness of ILR for detecting arrhythmia.

Atrial Fibrillation 40

Atrial Fibrillation Arrhythmia Heart Failure Tachycardia 40

Circulation

MARCH 17, 2024

Circulation, Volume 149, Issue 12 , Page e996-e996, March 19, 2024.

Pharmacology 45

Pharmacology Arrhythmia Circulation 45

HeartRhythm

APRIL 30, 2024

Congenital Long QT Syndrome (LQTS) can result in fatal cardiac arrhythmias. The main pharmacological treatment includes beta-blockers; however, while effective at reducing cardiac events, beta-blockers do not treat underlying mechanisms of the disease, and patients occasionally experience breakthrough cardiac events or side effects.

Pharmacology 40

Pharmacology Congenital Arrhythmia 40

HeartRhythm

APRIL 30, 2024

Congenital Long QT Syndrome (LQTS) can result in fatal cardiac arrhythmias. The main pharmacological treatment includes beta-blockers; however, while effective at reducing cardiac events, beta-blockers do not treat underlying mechanisms of the disease, and patients occasionally experience breakthrough cardiac events or side effects.

Pharmacology 40

Pharmacology Congenital Arrhythmia 40

Journal of Cardiovascular Pharmacology

MAY 7, 2024

Concerns regarding the risk of cardiac arrhythmia and death have been raised, yet the burden of HCQ and CQ-related cardiac toxicities remains unclear. Concerns regarding the risk of cardiac arrhythmia and death have been raised, yet the burden of HCQ and CQ-related cardiac toxicities remains unclear.

Sudden Cardiac Death 40

Sudden Cardiac Death Arrhythmia Article Outcomes 40

DAIC

FEBRUARY 27, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study. The acquisition of Laminar, Inc.

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

Journal of the American Heart Association

DECEMBER 29, 2023

ABSTRACTAtrial fibrillation (AF) is the most common cardiac arrhythmia. However, studies on how obesity affects pharmacologic or interventional AF treatments are limited. Journal of the American Heart Association, Ahead of Print. AF increases the risk of stroke, heart failure, dementia, and hospitalization.

Obesity 45

Obesity Atrial Fibrillation Heart Failure Dementia 45

Circulation

NOVEMBER 11, 2024

Cardiac fibrosis is a pathological hallmark of almost all forms of heart disease, characterized by excessive deposition of extracellular matrix (ECM) proteins by activated fibroblasts, leading to cardiomyocyte hypertrophy, arrhythmias, and heart failure.

Cardiac Function 40

Cardiac Function Pharmacology Innovation Heart Failure 40

The British Journal of Cardiology

NOVEMBER 29, 2023

The key risk factor for cardioembolic stroke is atrial fibrillation or flutter, and oral anticoagulation (OAC) is recommended in all but the lowest-risk patients with evidence of these arrhythmias. Overall, comprehensive assessment and pharmacological modification of risk factors are central to stroke prevention.

Stroke 52

Stroke Strokes Risk Factors Blood Pressure 52

Journal of Cardiovascular Electrophysiology

SEPTEMBER 7, 2023

Abstract Introduction Premature ventricular complexes (PVCs) are the most common ventricular arrhythmia that are encountered in the clinical practice. Both antiarrhythmic drugs (AADs) and catheter ablation (CA) are recognized treatment modalities for any cardiac arrhythmias.

Cardiomyopathy 40

Cardiomyopathy Pharmacology Coronary Artery Disease Ablation 40

Dr. Smith's ECG Blog

NOVEMBER 26, 2018

In some cases the ischemia can be seen "through" the flutter waves, whereas in other cases the arrhythmia must be terminated before the ischemia can be clearly distinguished. We discussed several pharmacologic and electrical options. 2) Tachycardia to this degree can cause ST segment changes in several ways.

Ischemia 52

Ischemia Atrial Flutter Arrhythmia Tachycardia 52

Cardiometabolic Health Congress

AUGUST 30, 2024

Pharmacological Interventions : Use of antihypertensive medications, lipid-lowering agents, and antidiabetic drugs. Arrhythmias : A leadless pacemaker-defibrillator system provides antitachycardia pacing for ventricular tachycardia in patients with subcutaneous ICDs.

Cardiac Rehabilitation 52

Cardiac Rehabilitation Heart Failure Quality of Life Aortic 52

Journal of Cardiovascular Pharmacology

DECEMBER 28, 2023

Amphetamine derivatives are used worldwide legally or illegally and intoxications may be accompanied by cardiac arrhythmias. Amphetamine derivatives are used worldwide legally or illegally and intoxications may be accompanied by cardiac arrhythmias.

Arrhythmia 52

Arrhythmia Article 52

Dr. Smith's ECG Blog

OCTOBER 23, 2023

T-wave alternans and the susceptibility to ventricular arrhythmias. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. Both ST segment and T wave alternans have been known to precede malignant ventricular arrhythmias. Pacing Clin Electrophysiol.

Tachycardia 123

Tachycardia Cardiac Arrest ICU Blog 123

Ken Grauer, MD

MARCH 12, 2023

What is unusual about this arrhythmia? Doing so suggests that the R-R interval of this exceedingly rapid arrhythmia is just a tiny amount over 1 large box — which corresponds to a ventricular rate just under 300/minute ( ie, between 290-300/minute ). How would YOU interpret the ECG in Figure-1 ?

Blog 78

Blog Atrial Flutter Arrhythmia AFIB 78

Journal of Cardiovascular Pharmacology

DECEMBER 3, 2010

Atrial fibrillation (AF) is the most common arrhythmia in humans. It affects 5% of the population over the age of 65 years and is projected to rise as the population ages. Experimental data from animal models of AF shows that AF is associated with progressive structural and electrical remodeling of the atria.

Atrial Fibrillation 40

Atrial Fibrillation Article Arrhythmia 40

Dr. Smith's ECG Blog

SEPTEMBER 7, 2020

If the rhythm converts and then reverts to tachycardia with either adenosine or electricity, Neither one of those modalities should be attempted until some longer acting pharmacological solution is given. WPW does not always have delta waves on the baseline ECG. This is called "Concealed conduction".

Tachycardia 52

Tachycardia Heart Disease Dysrhythmia Ablation 52

Dr. Smith's ECG Blog

NOVEMBER 19, 2016

myocardial infarction), arrhythmias, valvular pathology, shunts, or outflow obstructions. Fundamentally, cardiogenic shock is an issue of decreased cardiac output. This may be secondary to multiple factors, including decreased cardiac contractility (ie. As with other cases of shock, initial fluid resuscitation may be considered.

Ischemia 52

Ischemia Cardiogenic Shock Aortic Stenosis 52

Dr. Smith's ECG Blog

NOVEMBER 28, 2022

Both ST segment and T wave alternans have been known to precede malignant ventricular arrhythmias. This may result from fluctuations in heart rate or in nervous system activity or from pharmacologic treatment. In patients with a long QT — T wave alternans may forebode impending Torsades de Pointes.

Tachycardia 52

Tachycardia Pericarditis Ultrasound Blood Pressure 52